NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 207 filers reported holding NEKTAR THERAPEUTICS in Q1 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $20 | +33.3% | 16 | 0.0% | 0.00% | – |
Q1 2024 | $15 | +87.5% | 16 | 0.0% | 0.00% | – |
Q4 2023 | $8 | 0.0% | 16 | 0.0% | 0.00% | – |
Q3 2023 | $8 | -11.1% | 16 | 0.0% | 0.00% | – |
Q2 2023 | $9 | -30.8% | 16 | 0.0% | 0.00% | – |
Q1 2023 | $13 | – | 16 | -81.8% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 88 | -83.6% | 0.00% | – |
Q1 2022 | $2,000 | -66.7% | 535 | +78.3% | 0.00% | -100.0% |
Q1 2021 | $6,000 | +20.0% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $5,000 | -28.6% | 300 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $7,000 | +133.3% | 300 | +76.5% | 0.00% | 0.0% |
Q2 2017 | $3,000 | -25.0% | 170 | 0.0% | 0.00% | -50.0% |
Q1 2017 | $4,000 | +100.0% | 170 | 0.0% | 0.00% | +100.0% |
Q4 2016 | $2,000 | – | 170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
CM Management, LLC | 35,000 | $595,000 | 0.55% |
OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |